Imagenebio Stock Price Prediction

Intrinsic Valuation Low Real High 2.32 6.15 9.98 Details

Naive Forecast Low Next High 3.55 7.38 11.21 Details

Earnings Estimates (0) Low Projected EPS High -0.83 -0.83 -0.83 Details

ImageneBio After-Hype Price Density Analysis

ImageneBio Estimiated After-Hype Price Volatility

ImageneBio Stock Price Outlook Analysis

Notes

ImageneBio Hype Timeline

On the 28th of January ImageneBio is traded for 7.35. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.07. ImageneBio is expected to increase in value after the next headline, with the price projected to jump to 7.36 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.14%, whereas the daily expected return is currently at -0.15%. The volatility of related hype on ImageneBio is about 880.46%, with the expected price after the next announcement by competition of 7.42. The company reported the last year's revenue of 3.5 M. Reported Net Loss for the year was (49.23 M) with profit before taxes, overhead, and interest of 4.3 M. Considering the 90-day investment horizon the next expected press release will be in about 8 days. Check out ImageneBio Basic Forecasting Models to cross-verify your projections. For information on how to trade ImageneBio Stock refer to our How to Trade ImageneBio Stock guide.

ImageneBio Related Hype Analysis

ImageneBio Additional Predictive Modules

Most predictive techniques to examine ImageneBio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ImageneBio using various technical indicators. When you analyze ImageneBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of ImageneBio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ImageneBio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ImageneBio based on analysis of ImageneBio hews, social hype, general headline patterns, and widely used predictive technical indicators.

When running ImageneBio's price analysis, check to measure ImageneBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImageneBio is operating at the current time. Most of ImageneBio's value examination focuses on studying past and present price action to predict the probability of ImageneBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImageneBio's price. Additionally, you may evaluate how the addition of ImageneBio to your portfolios can decrease your overall portfolio volatility.